SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-001508
Filing Date
2024-01-05
Accepted
2024-01-05 16:05:12
Documents
12
Period of Report
2024-01-04
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191190-8k_citius.htm   iXBRL 8-K 28450
  Complete submission text file 0001213900-24-001508.txt   201859

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ctxr-20240104.xsd EX-101.SCH 3027
3 XBRL LABEL FILE ctxr-20240104_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ctxr-20240104_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT ea191190-8k_citius_htm.xml XML 3309
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 24516220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)